CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Casi Pharmaceuticals, Inc.  (CASI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Casi Pharmaceuticals's Leverage Ratio

CASI's quarterly Leverage Ratio and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:                        

CASI Leverage Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Equity Change 314.96 % - - - -
Y / Y Total Liabilities Change -29.79 % -41.84 % -26.2 % -25.64 % -17.68 %
Leverage Ratio MRQ 0.36 0.33 0.55 0.89 2.13
Overall Ranking # 731 # 645 # 1006 # 1645 # 2963
Seq. Equity Change -7.43 % 29.71 % 59.85 % 116.19 % -
Seq. Total Liabilities Change 0.19 % -20.67 % -2.35 % -9.55 % -17 %



Leverage Ratio first quarter 2017 Comment
Due to net new borrowings of 0.19%, Leverage Ratio detoriated to 0.36, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2017, 59 other companies have achieved lower Leverage Ratio than Casi Pharmaceuticals. While Leverage Ratio total ranking has deteriorated compare to previous quarter from 645 to 731.

Explain Leverage Ratio?
Who are CASI Customers?
Leverage Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 60
Sector # 236
S&P 500 # 731


Leverage Ratio Statistics
High Average Low
13.82 2.59 0.06
(Sep 30 2014)   (Jun 30 2014)


You need to upgrade your Flash Player


Financial Statements
Casi Pharmaceuticals's Equity $ 19 Millions Visit CASI's Balance sheet
Casi Pharmaceuticals's Total Liabilities $ 7 Millions Visit CASI's Balance sheet
Source of CASI's Sales Visit CASI's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2017, within Biotechnology & Drugs Industry Leverage RatioMar 31 2017 MRQ Total LiabilitiesMar 31 2017 MRQ Equity
Assembly Biosciences, Inc.  0.98 $ 66.396  Millions$ 67.888  Millions
Aviragen Therapeutics, Inc.  0.93 $ 22.500  Millions$ 24.200  Millions
Aytu Bioscience, Inc  0.87 $ 7.395  Millions$ 8.521  Millions
Biogen Inc.  0.85 $ 9,716.900  Millions$ 11,467.400  Millions
Acorda Therapeutics Inc  0.84 $ 567.585  Millions$ 676.127  Millions
Axovant Sciences Ltd.  0.78 $ 97.702  Millions$ 124.837  Millions
Alliance Bioenergy Plus, Inc.  0.72 $ 3.712  Millions$ 5.170  Millions
Neuralstem, Inc.  0.69 $ 6.781  Millions$ 9.780  Millions
Bio-techne Corp  0.69 $ 625.506  Millions$ 907.925  Millions
Tracon Pharmaceuticals, Inc.  0.65 $ 14.932  Millions$ 22.988  Millions
Dimension Therapeutics, Inc.  0.65 $ 30.738  Millions$ 47.489  Millions
Repligen Corp  0.64 $ 113.837  Millions$ 176.791  Millions
Cv Sciences, Inc.  0.63 $ 7.439  Millions$ 11.735  Millions
Eiger Biopharmaceuticals, Inc.  0.61 $ 18.897  Millions$ 30.870  Millions
Genocea Biosciences, Inc.  0.61 $ 20.121  Millions$ 33.084  Millions
Marina Biotech, Inc.  0.58 $ 1.973  Millions$ 3.419  Millions
Aeolus Pharmaceuticals, Inc.  0.57 $ 0.638  Millions$ 1.127  Millions
Enumeral Biomedical Holdings, Inc.  0.56 $ 1.109  Millions$ 1.964  Millions
Emergent Biosolutions Inc.  0.56 $ 339.004  Millions$ 610.419  Millions
Aptevo Therapeutics Inc.  0.55 $ 33.997  Millions$ 61.486  Millions
Citius Pharmaceuticals, Inc.  0.52 $ 7.343  Millions$ 13.992  Millions
Pdl Biopharma, Inc.  0.51 $ 390.577  Millions$ 762.936  Millions
Crispr Therapeutics Ag  0.50 $ 107.171  Millions$ 215.175  Millions
Relmada Therapeutics, Inc.  0.49 $ 1.368  Millions$ 2.802  Millions
Microbot Medical Inc.  0.46 $ 1.788  Millions$ 3.889  Millions
Tyme Technologies, Inc.  0.45 $ 3.327  Millions$ 7.392  Millions
Soligenix, Inc.  0.45 $ 2.593  Millions$ 5.816  Millions
Heska Corp  0.44 $ 40.867  Millions$ 92.698  Millions
Pulmatrix, Inc.  0.43 $ 6.892  Millions$ 15.902  Millions
Voyager Therapeutics, Inc.  0.43 $ 52.393  Millions$ 122.697  Millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com